Product Images Hydralazine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Hydralazine Hydrochloride NDC 43066-041 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image-01-hydralazine-structural-formula - image 01 hydralazine structural formula

image-01-hydralazine-structural-formula - image 01 hydralazine structural formula

image-02-container-label - image 02 container label

image-02-container-label - image 02 container label

This text provides information about the medication with the NDC code 43066-041-01, which is for intravenous use. It includes details on storage conditions (20°C to 25°C) and the usual dosage of 20 mg/mL for hydralazine hydrochloride. The medication is in a 1mL single-dose vial manufactured by Baxter Healthcare Corporation in the USA. It is indicated for intramuscular or injections.*

image-03-carton-label-01 - image 03 carton label 01

image-03-carton-label-01 - image 03 carton label 01

This text is a detailed description of Hydralazine Hydrochloride Injection. It states the active ingredient, Hydralazine hydrochloride USP, 20 mg per mL, along with the inactive components propylene glycol USP and water for injection. The solution has a pH range of 3.4 to 4.0 and includes preservatives: Methylparaben NF and Propylparaben NF. It is intended for emergency use in patients who are unable to take oral medications, and can be administered intramuscularly or intravenously. The drug is presented in single-dose vials containing 1 mL each.*

image-04-carton-label-02 - image 04 carton label 02

image-04-carton-label-02 - image 04 carton label 02

This is a description of a pharmaceutical product labeled as hydrochloride injection for intramuscular or intravenous use. It comes in single-dose vials and is manufactured by Baxter. The usual dosage information is included in the package insert, and storage instructions recommend keeping it at 20°C to 25°C. The product is sterile and nonpyrogenic. Unused portions should be discarded. Additional details may be available for production purposes.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.